InvestorsHub Logo
Followers 789
Posts 39077
Boards Moderated 15
Alias Born 06/20/2009

Re: None

Wednesday, 11/11/2009 1:10:23 PM

Wednesday, November 11, 2009 1:10:23 PM

Post# of 52074
An oldie but goodie! Wanted to pull this back up & ask how long do you think it will be before the next uplisting wink
No looking back from NASDAQ because the Sky's the Limit with MZEI

Sky

Posted by: Threw-er-back Date: Monday, October 19, 2009 6:09:23 AM
In reply to: None Post # of 2233 [Send a link via email]
Uplisting is always a beautiful thing ;o)


Medizone International, Inc. Announces OTCBB Listing
SAN FRANCISCO, Sept. 8 /PRNewswire-FirstCall/ -- Developer of ground-breaking ozone-based hospital sterilization technology -- AscepticSure(TM), Medizone announced today that its common stock has begun trading on the OTC Bulletin Board (OTC Bulletin Board: MZEI - News). The company's common stock was previously quoted on the Pink Sheets.

"While we have noticed over the past several months that many companies are de-listing from NASDAQ and the OTCBB due to various conditions and circumstances, we are pleased that we have moved up on the listing ladder to the OTCBB from the Pink Sheets," said Edwin G. Marshall, Chief Executive Officer of Medizone. "We are pleased to take this step to increase the company's exposure to investors and market makers, enhance liquidity for shareholders and institutions, and bring an added credibility to our common stock," continued Mr. Marshall.
Medizone International, Inc., is a research and development company engaged in developing its' AsepticSure(TM) technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. Trials conducted at Medizone's laboratory located in Innovation Park at Queens University have proven very successful and will now proceed to a hospital mock-up followed by hospital beta testing of the production prototype.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

Visit my favorite board, Chrissy's Profit Palace for a wealth of knowledge & the knowledge of wealth!
http://investorshub.advfn.com/boards/board.aspx?board_id=16192

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.